Veritas Revenue Up 55 Percent Over Year-Ago Quarter; Peri-Strips Revenue Sets Quarterly Record; Record Microsurgery Revenue Up 13 Percent [...]
Microbix Biosystems Inc. (MBX:TSX), a biotechnology company focused on virology and biological technologies, reported sales volume grew by 11% for the first nine months of fiscal 2010, compared to the same period in 2009. Double digit sales growth was, however, offset by the impact on revenue of strongly negative currency exchange rates.Revenue for the third [...]
POZEN Inc. (NASDAQ:POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced results for the second quarter ended June 30, 2010. Corporate Highlights Include: The U.S. Food and Drug Administration (FDA) approved VIMOVO? (naproxen and esomeprazole magnesium) (see About VIMOVO), and POZEN transferred ownership of the U.S. regulatory filings to AstraZeneca.POZEN completed enrollment [...]
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, reported financial results for the second quarter ended June 30, 2010.Bioject reported revenues of $1.2 million for the quarter ended June 30, 2010, compared to revenues of $1.7 million in the comparable 2009 period. Product sales were $1.0 million in the 2010 [...]
Stocksource.us brings you all the Stocks in the News: Prospect Medical Holdings Inc. (PZZ), Hauppauge Digital Inc. (NASDAQ: HAUP), KIT digital Inc. (NASDAQ:KITD), THQ Inc. (NASDAQ: THQI)Receive all the news and alerts first. Sign up for the news letter :http://www.stocksource.usFor stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny-stockProspect Medical Holdings [...]
LOS ANGELES Prospect Medical Holdings Inc., which has agreed to be acquired by a private equity firm, said Tuesday it turned a profit in its fiscal third quarter as revenue edged up 2 percent.The Los Angeles company has five hospitals in Southern California and provides health care management services to people enrolled in HMO [...]
Q3 FY 2010 Highlights Compared to Q3 FY 2009 Revenues increased 2.3% to $116.9 million from $114.3 million [...]
WASHINGTON Drugmaker Eli Lilly and Co. spent $1.59 million in the second quarter lobbying the federal government on an array of trade issues and health care reform.The Indianapolis-based drugmaker lobbied on German and Greek pricing reforms and Polish and Italian market access. It lobbied on counterfeit medicines, Russian data exclusivity and financial derivatives according [...]
ATLANTA, Aug. 12, 2010 (GLOBE NEWSWIRE) Alimera Sciences, Inc., (Nasdaq:ALIM), ("Alimera"), today announced financial results for the second quarter ended June 30, 2010 and provided an update on progress toward achieving its 2010 goals. "We are pleased that we successfully achieved our regulatory submission goals for our lead product candidate, Iluvien for the treatment of [...]
EWING, N.J.(BUSINESS WIRE) Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the second quarter ended June 30, 2010. Quarter and Recent Highlights [...]
